Sofie Voet

发表

Two distinct ubiquitin-binding motifs in A20 mediate its anti-inflammatory and cell-protective activities

M. Bertrand, L. Catrysse, S. Janssens, 2020, Nature Immunology.

S100B Is a Potential Disease Activity Marker in Nonsegmental Vitiligo.

E. Hoste, Sofie Voet, N. van Geel, 2017, The Journal of investigative dermatology.

A20 critically controls microglia activation and inhibits inflammasome-dependent neuroinflammation

Steffen Jung, P. Callaerts, R. Vandenbroucke, 2018, Nature Communications.

Pharmacological inhibition of MALT1 protease activity protects mice in a mouse model of multiple sclerosis

M. Prinz, D. Krappmann, G. van Loo, 2014, Journal of Neuroinflammation.

Microglia in Central Nervous System Inflammation and Multiple Sclerosis Pathology.

M. Prinz, G. van Loo, Sofie Voet, 2019, Trends in molecular medicine.

Inflammasomes in neuroinflammatory and neurodegenerative diseases

G. van Loo, M. Lamkanfi, Geert van Loo, 2019, EMBO molecular medicine.

Pharmacological inhibition of MALT1 protease activity protects mice in a mouse model of multiple sclerosis

M. Prinz, D. Krappmann, G. van Loo, 2014, Journal of Neuroinflammation.

OTULIN prevents liver inflammation and hepatocellular carcinoma by inhibiting FADD- and RIPK1 kinase-mediated hepatocyte apoptosis

M. Bertrand, M. Pasparakis, A. de Bruin, 2019, bioRxiv.

Cardiovascular and pharmacological implications of haem-deficient NO-unresponsive soluble guanylate cyclase knock-in mice

R. Karas, J. Stasch, J. van de Voorde, 2015, Nature Communications.

Two distinct ubiquitin-binding motifs in A20 mediate its anti-inflammatory and cell-protective activities

M. Bertrand, L. Catrysse, S. Janssens, 2020, Nature Immunology.

Inflammasome signaling is dispensable for ß-amyloid-induced neuropathology in preclinical models of Alzheimer’s disease

R. Vandenbroucke, G. van Loo, M. Lamkanfi, 2024, Frontiers in immunology.